SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001104659-23-127862
Filing Date
2023-12-21
Accepted
2023-12-21 06:00:58
Documents
78
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A adxn-20230630x6ka.htm 6-K/A 18560
2 EXHIBIT-99.1 adxn-20230630xex99d1.htm   iXBRL EX-99.1 1612931
  Complete submission text file 0001104659-23-127862.txt   6637101

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adxn-20230630.xsd EX-101.SCH 65683
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adxn-20230630_cal.xml EX-101.CAL 59834
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adxn-20230630_def.xml EX-101.DEF 147578
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxn-20230630_lab.xml EX-101.LAB 414387
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxn-20230630_pre.xml EX-101.PRE 286605
72 EXTRACTED XBRL INSTANCE DOCUMENT adxn-20230630xex99d1_htm.xml XML 1343222
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39179 | Film No.: 231502714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)